The Coronavirus in the U.S. and Japan: Perspectives from the Health Sector (WEBINAR)





  • When
  • Tags:

The Coronavirus in the U.S. and Japan: Perspectives from the Health Sector

When: Thursday, April 2 (U.S.) / Friday, April 3 (Japan)
Time: 6:30pm – 7:30pm EST / 7:30am – 8:30am JST
Registration: Click here
This webinar is free to attend and open to the public.

The U.S.-Japan Council is pleased to offer a public webinar, titled “The Coronavirus in the U.S. and Japan: Perspectives from the Health Sector,” which will explore the evolving impact of the novel coronavirus in the United States and Japan and lessons we might learn from the experiences of our two countries. It will feature immunologist Dr. Mary Collins, Provost of the Okinawa Institute of Science and Technology (OIST); Dr. Hiroyuki Fujita, Founder, President & CEO of Quality Electrodynamics and Chairman of the Board at the Cleveland Clinic; and moderator David Janes, Member of the USJC Program Development Committee and Senior Advisor for Institutional Development at OIST.

SPEAKERS

Professor Mary Collins, Provost, Okinawa Institute of Science and Technology Graduate University

photo of Professor Mary Collins

Professor Collins studied Biochemistry at Cambridge University then moved to the University of London at the Imperial Cancer Research Fund for her PhD. Dr. Collins worked as a post-doctoral fellow on molecular immunology at University College London, then the Whitehead Institute, MIT. She started her own group at the Institute of Cancer Research in 1987. Dr. Collins moved to University College London as Professor of Immunology in 1997. From 2005 to 2015 she was Director of the Britain’s Medical Research Council Centre for Medical Molecular Virology. After heading the Division of Infection and Immunity at University College London for 10 years, Dr. Collins was Dean of the Faculty of Life Sciences at University College London from 2009 until 2014. In September 2014 Dr. Collins took up a secondment at the National Institute for Biological Standards and Control to head a new Division of Advanced Therapies.

Dr. Hiroyuki Fujita, USJC Board of Councilors; Founder and CEO, Quality Electrodynamics (QED) CTO, CTMR Division, Canon Medical Systems Corporation; Chairman of the Board, Cleveland Clinic Hillcrest Hospital; Honorary Consul of Japan in Cleveland Ohio State University Board

photo of Dr. Hiroyuki Fujita

Dr. Fujita leads Quality Electrodynamics, a global developer, manufacturer and supplier of Magnetic Resonance Imaging (MRI) technology. He authored 17 patents and published over 40 scientific papers and abstracts. Dr. Fujita serves as Adjunct Full Professor of Physics, Department of Physics, and Radiology, Department of Radiology, School of Medicine, at Case Western Reserve University (CWRU) in Ohio, and Adjunct Full Professor, School of Information Technology and Electrical Engineering at The University of Queensland, Australia, and is a Senior Fellow of the International Society for Magnetic Resonance in Medicine. Dr. Fujita serves on the boards of numerous organizations, most notably The Ohio State University, The Cleveland Orchestra, The Cleveland Foundation, Cleveland Clinic Hillcrest Hospital, the Cleveland Council on World Affairs, and Global Cleveland. Dr. Fujita is a Member of the USJC Board of Councilors.

David P. Janes (Moderator), Senior Advisor, Institutional Development in the Office of the President, Okinawa Institute of Science and Technology Graduate University

David Janes leads OIST’s development efforts in the United States and assists OIST in connecting to the U.S.-Japan world. Aiming to be the world’s best science and technology university and one of the most innovative educational institutions, OIST is poised to help with the sustainable development of Okinawa, with scientific research in Japan, and contribute to science and technology knowledge globally. Previously, Mr. Janes was Director of Foundation Grants and Assistant to the President at the United States-Japan Foundation, where he led the Foundation’s multi-million dollar grant-making program and served as the public face of the Foundation to potential and current grantees in the U.S. and Japan. He served at the Foundation for nearly 18 years and managed over 100 active grantees annually and had key responsibility for fiscal and programmatic oversight of these organizations’ grant-related programs. Mr. Janes is a Council Leader and a member of the USJC Program Development Committee.